Back to search

University of Edinburgh

Modelling corneal injury and infection in zebrafish larvae: defining the role of platelet-activating factor in microbial keratitis

Abstract

dc:description.abstract

Microbial keratitis (MK), infection of the cornea, the clear window to the eye, remains a leading cause of blindness globally affecting 1.5 to 2 million cases annually. MK can be caused by a variety of pathogens including bacteria, viruses, fungi or parasites with predominance of fungal keratitis in Asian countries and bacterial keratitis in western countries. The incidence of this disease varies widely with the highest estimated incidence in developing countries such as South India, Bhutan, Burma and Nepal. The incidence of this disease that predominantly affects working-age adults is worryingly increasing and hence has been labelled a 'Neglected Tropical Disease'. Treatment of this disease predominantly relies of eradication of pathogens using antimicrobials. However, while it is well-accepted that dysregulated inflammation contributes to tissue damage that manifests as corneal thinning, scarring or corneal perforation, there are limited options for immunomodulation. Corticosteroids are sparingly used in clinic to modulate inflammation as they are associated with side effects such as glaucoma, cataract, impaired wound healing and critically, exacerbation of MK caused by fungi or Acanthamoeba. Indeed, the critical need for novel therapeutic options has been recognised by the UK clinical eye research strategy as the most important question in corneal research. While there are models commonly used to study MK, none allow in-depth interrogation of immune cell response to MK, hence limiting the potential for discovering novel therapeutics for this disease. Inflammation is regulated by various inflammatory mediators. Among these, platelet-activating factor (PAF) is a potent phospholipid mediator and signalling molecule that contributes to the initiation, amplification and possibly the resolution of inflammatory responses. It has also been shown to have a negative effect on wound healing but it's role in MK has not been characterised. The hypothesis of this project is that zebrafish (Danio rerio) larvae can be utilised to study MK immune response by taking advantage of its optical clarity and fluorescently-labelled immune cells. PAF is hypothesised to play an important role in MK by enhancing the inflammatory response, and if so, can be a useful therapeutic target by inhibiting it action. A novel zebrafish larvae model of corneal injury and infection was developed and characterised using the Tg(mpx:GFP; mpeg1:mCherry) line which have green fluorescent neutrophils and red fluorescent macrophages. To ensure consistency in injury and improve throughput by keeping larvae in a horizontal orientation, the Zebrafish Injury Platform (ZIP), a mould that conforms to the shape of 3 to 5 days post-fertilisation larvae was designed. Scanning electron microscopy validated that the injury created by scratching the eye mechanically with a needle led to exposure of the corneal stroma, akin to human disease. I showed that wounding of the zebrafish larval cornea led to a rapid influx of neutrophils to the cornea by 2 hours post-injury (hpi) followed by macrophages at 4 hpi. The inflammatory response resolved rapidly, returning to baseline levels by 6 hpi. I also showed that the recruitment of immune cells was exaggerated when manipulated with exogenous lipopolysaccharides (LPS), lipoteichoic acid (LTA), N-formylmethionine-leucyl-phenylalanine (fMLF) and leukotriene B4 (LTB4) – consistent with their known effects on the human immune response. This provides validation of the model as a useful method for studying the immune response to MK. After characterising and validating the larval zebrafish corneal injury and infection model, it was then used to study PAF and its influence on the immune response to corneal injury and infection. This was achieved using pharmacological and genetic perturbations. Treatment of injured larvae in exogenous PAF increased neutrophil and macrophage recruitment and this was reversed with the addition of WEB 2086, a PAF receptor antagonist, thereby confirming that the effect is mediated by the PAF receptor. This was further validated using CRISPR-Cas9 mediated knockdown of the PAF receptor which led to dampening of the immune response, not rescued by the addition of exogenous PAF. Interrogation of the roles of lysophosphatidylcholine acyltransferase (LPCAT) isoforms 1 and 2, enzymes involved in the final biosynthetic step of PAF generation via the remodelling pathway, were also performed using CRISPR-Cas9 mediated knockdown. While LPCAT1 knockdown did not influence the immune response, LPCAT2 knockdown attenuated immune cell recruitment suggesting that it is involved in mediating PAF generation in response to inflammatory stimuli in the cornea. This was validated using TSI-01, a pharmacological LPCAT2 inhibitor, which also showed a dose-response attenuation in the number of immune cells recruited to corneal injury. In summary, zebrafish larvae are a useful model for studying the innate immune response to corneal injury and infection and recapitulates the immune response to chemoattractants as is observed in humans. PAF plays an important role in immune cell recruitment to corneal injury and infection and represents a promising therapeutic target, offering dual benefits through modulation of neutrophil and macrophage recruitment while simultaneously promoting wound healing.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Cheng Kah Wai, Kelvin
Advisors dc:contributor.advisor
  • Rossi, Adriano
  • Mills, Beth

Subjects

dc:subject × 8

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Edinburgh
Base URL
era.ed.ac.uk/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Cheng Kah Wai, Kelvin. Modelling corneal injury and infection in zebrafish larvae: defining the role of platelet-activating factor in microbial keratitis. 2026. https://hdl.handle.net/1842/45459